UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer

Annals of oncology, 2015-06, Vol.26 (6), p.1194-1200

2015

Volltextzugriff (PDF)

A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC)

Annals of oncology, 2014-04, Vol.25 (4), p.824-831

2014

Volltextzugriff (PDF)

A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer

Annals of oncology, 2013-07, Vol.24 (7), p.1777-1785

2013

Volltextzugriff (PDF)

P-099Advanced hepatocellular cancer treated with sorafenib - analysis of prognostic factors for patients' survival: single institution experience

Annals of oncology, 2016-06, Vol.27 (suppl_2), p.ii29-ii29

2016

Volltextzugriff (PDF)

Dose escalation to rash for erlotinib plus gemcitabine for metastatic pancreatic cancer: the phase II RACHEL study

British journal of cancer, 2014-11, Vol.111 (11), p.2067-2075

2014

Volltextzugriff (PDF)

The 3020insC allele of the NOD2 gene in breast cancer patients – a clinicopathological analysis

Breast (Edinburgh), 2017-03, Vol.32, p.S34-S34

2017

Volltextzugriff (PDF)

P029 The relationship between tumour lymphocyte infiltration and survival in early breast cancer patients

Breast (Edinburgh), 2015-03, Vol.24, p.S36-S36

2015

Volltextzugriff (PDF)

P031 Correlation between CHEK2 mutation and clinicopathological factors in early breast cancer patients

Breast (Edinburgh), 2015-03, Vol.24, p.S37-S37

2015

Volltextzugriff (PDF)

253 A comparison between Chek 2 mutation carriers and non carriers in early breast cancer patients: A clinicopathological analysis

European journal of cancer (1990), 2015-09, Vol.51, p.S44-S44

2015

Volltextzugriff (PDF)

Intermediate-dose Ara-C plus G-CSF for stem cell mobilization in patients with lymphoid malignancies, including predicted poor mobilizers

Bone marrow transplantation (Basingstoke), 2013-07, Vol.48 (7), p.915-921

2013

Volltextzugriff (PDF)

Impact of Total Thoracic Radiation Dose and Dose Fractionation on Overall Survival in Limited-Disease Small Cell Lung Cancer: A Retrospective Study on 456 Patients

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S588-S589

2011

Volltextzugriff (PDF)

279P Prognostic significance of pre-treatment NLR and PLR in BRCA1-associated epithelial ovarian cancer–a retrospective analysis

Annals of oncology, 2015-12, Vol.26, p.ix80-ix80

2015

Volltextzugriff (PDF)

Randomized Clinical Trial on Postoperative Continuous 7-days-a-week Radiotherapy vs. Postoperative Radiochemotherapy in Squamous-cell Head and Neck Cancer: A Report on Acute Normal Tissue Reactions

International journal of radiation oncology, biology, physics, 2010, Vol.78 (3), p.S442-S442

2010

Volltextzugriff (PDF)

The Association of Tumour Lymphocyte Infiltration with Clinicopathological Features in Breast Cancer Patients

Annals of oncology, 2014-09, Vol.25, p.iv569

2014

Volltextzugriff (PDF)

1647PTHE ASSOCIATION OF TUMOUR LYMPHOCYTE INFILTRATION WITH CLINICOPATHOLOGICAL FEATURES IN BREAST CANCER PATIENTS

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv569-iv569

2014

Volltextzugriff (PDF)

Age alone or Charlson comorbidity index – what guides anticancer treatment choice in newly diagnosed, non-metastatic breast cancer in the real life setting?

Annals of oncology, 2016-10, Vol.27, p.vi64-vi64

2016

Volltextzugriff (PDF)

P-099 Advanced hepatocellular cancer treated with sorafenib - analysis of prognostic factors for patients' survival: single institution experience

Annals of oncology, 2016-06, Vol.27, p.ii29-ii29

2016

Volltextzugriff (PDF)

Abstract P2-07-13: TP53 gene polymorphisms (c.[215G>C]) in breast cancer patients and predisposition to family cancers- Single center experience

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P2-P2-07-13

2017

Volltextzugriff (PDF)

The comparison between TP53 gene polymorphisms (c.[215G > C]) homozygotes and heterozygotes in breast cancer patients: a clinicopathological analysis

Annals of oncology, 2016-10, Vol.27, p.vi547-vi547

2016

Volltextzugriff (PDF)

5166 The prognostic significance of age at diagnosis in patients with breast cancer younger than 35 years

European journal of cancer supplements, 2009, Vol.7 (2), p.310-310

2009

Volltextzugriff (PDF)

Long-term response to mTOR inhibitors (everolimus) in mRCC patients: Single institution experience

European urology supplements : official journal of the European Association of Urology, 2016-12, Vol.15 (13), p.e1735-e1735

2016

Volltextzugriff (PDF)

P034 - The 3020insC allele of the NOD2 gene in breast cancer patients – a clinicopathological analysis

Breast (Edinburgh), 2017-03, Vol.32, p.S34-S34

2017

Volltextzugriff (PDF)

894PPRECEDENT SUBSET ANALYSIS: SAFETY AND DISEASE CONTROL WITH VINTAFOLIDE MONOTHERAPY FOLLOWING DISCONTINUATION OF PEGYLATED LIPOSOMAL DOXORUBICIN (PLD)

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv312-iv312

2014

Volltextzugriff (PDF)

Precedent Subset Analysis: Safety and Disease Control with Vintafolide Monotherapy Following Discontinuation of Pegylated Liposomal Doxorubicin (Pld)

Annals of oncology, 2014-09, Vol.25, p.iv312

2014

Volltextzugriff (PDF)

1 – 25 von 98

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(82)

Publikationsform

Artikel
(82)
Reviews
(14)
Bücher
(2)

Sprache

Englisch
(78)
Spanisch
(11)
Deutsch
(5)
Polnisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Life Sciences & Biomedicine
(22)
Humans
(18)
Female
(15)
Male
(14)
Middle Aged
(14)
Biological And Medical Sciences
(11)
Adult
(10)
Medical Sciences
(10)
Aged
(9)
Hematology, Oncology And Palliative Medicine
(9)
Oncology
(8)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(6)
Latin America
(6)
Aged, 80 And Over
(5)
Animals
(5)
Clinical Neurology
(5)
Neurosciences & Neurology
(5)
Urology
(5)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer

A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC)

A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer

P-099Advanced hepatocellular cancer treated with sorafenib - analysis of prognostic factors for patients' survival: single institution experience

Dose escalation to rash for erlotinib plus gemcitabine for metastatic pancreatic cancer: the phase II RACHEL study

The 3020insC allele of the NOD2 gene in breast cancer patients – a clinicopathological analysis

P029 The relationship between tumour lymphocyte infiltration and survival in early breast cancer patients

P031 Correlation between CHEK2 mutation and clinicopathological factors in early breast cancer patients

253 A comparison between Chek 2 mutation carriers and non carriers in early breast cancer patients: A clinicopathological analysis

Intermediate-dose Ara-C plus G-CSF for stem cell mobilization in patients with lymphoid malignancies, including predicted poor mobilizers

Impact of Total Thoracic Radiation Dose and Dose Fractionation on Overall Survival in Limited-Disease Small Cell Lung Cancer: A Retrospective Study on 456 Patients

279P Prognostic significance of pre-treatment NLR and PLR in BRCA1-associated epithelial ovarian cancer–a retrospective analysis

Randomized Clinical Trial on Postoperative Continuous 7-days-a-week Radiotherapy vs. Postoperative Radiochemotherapy in Squamous-cell Head and Neck Cancer: A Report on Acute Normal Tissue Reactions

The Association of Tumour Lymphocyte Infiltration with Clinicopathological Features in Breast Cancer Patients

1647PTHE ASSOCIATION OF TUMOUR LYMPHOCYTE INFILTRATION WITH CLINICOPATHOLOGICAL FEATURES IN BREAST CANCER PATIENTS

Age alone or Charlson comorbidity index – what guides anticancer treatment choice in newly diagnosed, non-metastatic breast cancer in the real life setting?

P-099 Advanced hepatocellular cancer treated with sorafenib - analysis of prognostic factors for patients' survival: single institution experience

Abstract P2-07-13: TP53 gene polymorphisms (c.[215G>C]) in breast cancer patients and predisposition to family cancers- Single center experience

The comparison between TP53 gene polymorphisms (c.[215G > C]) homozygotes and heterozygotes in breast cancer patients: a clinicopathological analysis

Hodgkin lymphoma of the elderly patients: a retrospective multicenter analysis from the Polish Lymphoma Research Group

5166 The prognostic significance of age at diagnosis in patients with breast cancer younger than 35 years

Long-term response to mTOR inhibitors (everolimus) in mRCC patients: Single institution experience

P034 - The 3020insC allele of the NOD2 gene in breast cancer patients – a clinicopathological analysis

894PPRECEDENT SUBSET ANALYSIS: SAFETY AND DISEASE CONTROL WITH VINTAFOLIDE MONOTHERAPY FOLLOWING DISCONTINUATION OF PEGYLATED LIPOSOMAL DOXORUBICIN (PLD)

Precedent Subset Analysis: Safety and Disease Control with Vintafolide Monotherapy Following Discontinuation of Pegylated Liposomal Doxorubicin (Pld)

Suchergebnisse filtern